Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA Assay

PURPOSE: Gene fusions are established oncogenic drivers and emerging therapeutic targets in advanced colorectal cancer. This study aimed to detail the frequencies and clinicopathological features of gene fusions in colorectal cancer using a circulating tumor DNA assay. METHODS: Circulating tumor DNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Clifton, Katherine, Rich, Thereasa A., Parseghian, Christine, Raymond, Victoria M., Dasari, Arvind, Pereira, Allan Andresson Lima, Willis, Jason, Loree, Jonathan M., Bauer, Todd M., Chae, Young Kwang, Sherrill, Gary, Fanta, Paul, Grothey, Axel, Hendifar, Andrew, Henry, David, Mahadevan, Daruka, Nezami, Mohammad Amin, Tan, Benjamin, Wainberg, Zev A., Lanman, Richard, Kopetz, Scott, Morris, Van
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526699/
https://www.ncbi.nlm.nih.gov/pubmed/33015522
http://dx.doi.org/10.1200/PO.19.00141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526699/
https://www.ncbi.nlm.nih.gov/pubmed/33015522
http://dx.doi.org/10.1200/PO.19.00141

Ejemplares similares